Dyne Therapeutics, Inc. (DYN)

SEC filing

Dyne Therapeutics, Inc.

DYN · CIK 1818794

4 · Oct 6, 2026 · Director Posner Brian S bought 2,500 shares at $16.00/share ($40,000)

Director Posner Brian S bought 2,500 shares at $16.00/share ($40,000)

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.